Dr. Shah on CAR T-cell Therapy's Effectiveness in ALL
In Partnership With:
Bijal D. Shah, MD, medical oncology, of Moffit Cancer Center, explains why chimeric antigen receptor (CAR) T-cell therapy has shown the most progress in acute lymphoblastic leukemia (ALL).
Bijal D. Shah, MD, medical oncology, of Moffit Cancer Center, explains why chimeric antigen receptor (CAR) T-cell therapy has shown the most progress in acute lymphoblastic leukemia (ALL).
Related Videos
Related Content
%201%20(1)%20copy.jpg?fit=crop&auto=format)
